Q4 and FY 2019 revenue is expected to be ~$10M and ~$14M, respectively.
In the U.S., Q4 revenue was ~$8.4M following the launch of commercial sales of the Axonics r-SNM System.
Revenue from international markets totaled ~$1.6M in Q4.
For all of 2019, international sales from Europe and Canada totaled ~$5.4M.
Complete financial results for Q4 and FY 2019 are anticipated to be announced on March 4.
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.